120 related articles for article (PubMed ID: 17624591)
1. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
Gaudet MM; Gammon MD; Bensen JT; Sagiv SK; Shantakumar S; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Breast Cancer Res Treat; 2008 Mar; 108(1):93-9. PubMed ID: 17624591
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955
[TBL] [Abstract][Full Text] [Related]
4. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.
Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM
Breast Cancer Res Treat; 2006 Sep; 99(1):1-7. PubMed ID: 16752224
[TBL] [Abstract][Full Text] [Related]
5. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue.
Rundle A; Tang D; Zhou J; Cho S; Perera F
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1079-85. PubMed ID: 11045791
[TBL] [Abstract][Full Text] [Related]
6. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.
Gammon MD; Santella RM; Neugut AI; Eng SM; Teitelbaum SL; Paykin A; Levin B; Terry MB; Young TL; Wang LW; Wang Q; Britton JA; Wolff MS; Stellman SD; Hatch M; Kabat GC; Senie R; Garbowski G; Maffeo C; Montalvan P; Berkowitz G; Kemeny M; Citron M; Schnabel F; Schuss A; Hajdu S; Vinceguerra V
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):677-85. PubMed ID: 12163319
[TBL] [Abstract][Full Text] [Related]
7. Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer.
Shen J; Liao Y; Hopper JL; Goldberg M; Santella RM; Terry MB
Br J Cancer; 2017 Apr; 116(9):1229-1233. PubMed ID: 28350789
[TBL] [Abstract][Full Text] [Related]
8. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer.
Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP
Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004
[TBL] [Abstract][Full Text] [Related]
9. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females.
Shantakumar S; Gammon MD; Eng SM; Sagiv SK; Gaudet MM; Teitelbaum SL; Britton JA; Terry MB; Paykin A; Young TL; Wang LW; Wang Q; Stellman SD; Beyea J; Hatch M; Camann D; Prokopczyk B; Kabat GC; Levin B; Neugut AI; Santella RM
J Expo Anal Environ Epidemiol; 2005 Nov; 15(6):482-90. PubMed ID: 15856074
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in DNA repair genes, traffic-related polycyclic aromatic hydrocarbon exposure and breast cancer incidence.
Mordukhovich I; Beyea J; Herring AH; Hatch M; Stellman SD; Teitelbaum SL; Richardson DB; Millikan RC; Engel LS; Shantakumar S; Steck SE; Neugut AI; Rossner P; Santella RM; Gammon MD
Int J Cancer; 2016 Jul; 139(2):310-21. PubMed ID: 26946191
[TBL] [Abstract][Full Text] [Related]
12. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women.
Lajin B; Alhaj Sakur A; Alachkar A
Breast Cancer Res Treat; 2013 Apr; 138(2):611-9. PubMed ID: 23468244
[TBL] [Abstract][Full Text] [Related]
13. Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors.
Mordukhovich I; Rossner P; Terry MB; Santella R; Zhang YJ; Hibshoosh H; Memeo L; Mansukhani M; Long CM; Garbowski G; Agrawal M; Gaudet MM; Steck SE; Sagiv SK; Eng SM; Teitelbaum SL; Neugut AI; Conway-Dorsey K; Gammon MD
Environ Health Perspect; 2010 Apr; 118(4):511-8. PubMed ID: 20064791
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.
Shen J; Gammon MD; Terry MB; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Eur J Cancer; 2008 Mar; 44(5):710-7. PubMed ID: 18053706
[TBL] [Abstract][Full Text] [Related]
15. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
[TBL] [Abstract][Full Text] [Related]
16. Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China.
Lan Q; Shen M; Berndt SI; Bonner MR; He X; Yeager M; Welch R; Keohavong P; Donahue M; Hainaut P; Chanock S
Lung Cancer; 2005 Sep; 49(3):317-23. PubMed ID: 15921821
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
18. Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations.
Denisov EV; Sukhanovskaya TV; Dultseva TS; Malinovskaya EA; Litviakov NV; Slonimskaya EM; Choinzonov EL; Cherdyntseva NV
Genet Test Mol Biomarkers; 2011 Dec; 15(12):901-7. PubMed ID: 21810023
[TBL] [Abstract][Full Text] [Related]
19. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
20. The interaction between alcohol consumption and GSTM1 genotype on polycyclic aromatic hydrocarbon-DNA adduct levels in breast tissue.
Rundle A; Tang D; Mooney L; Grumet S; Perera F
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):911-4. PubMed ID: 14504203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
